Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Plos One|October 6, 2016
The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for ProductionGaurav Kanojia, Rimko Ten Have, Arjen Bakker, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2010
Bioneedles as alternative delivery system for hepatitis B vaccineHoang J H B Hirschberg, Gijsbert G P van de Wijdeven, Heleen Kraan, et al.Vaccines|October 28, 2025
Improving the Suitability of Vaccine Design for Immunisation Programmes and Enhancing Vaccine Policy Quality Through User ResearchStefano Malvolti, Melissa Malhame, Adam Soble, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 4, 2012
Pulmonary vaccine delivery: a realistic approach?Wouter F Tonnis, Gideon F Kersten, Henderik W Frijlink, et al.The AAPS Journal|March 3, 2010
Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperaturesFelix Geeraedts, Vinay Saluja, Wouter ter Veer, et al.Vaccine|October 10, 2021
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countriesBirgitte Giersing, Natasha Shah, Debra Kristensen, et al.Plos One|March 28, 2014
Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responsesPeter C Soema, Geert-Jan Willems, Klaas van Twillert, et al.Vaccine|March 25, 2025
Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy AllianceCollrane Frivold, Birgitte Giersing, Jean-Pierre Amorij, et al.Plos One|March 10, 2016
Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production ProcessesTheone C Kon, Adrian Onu, Laurentiu Berbecila, et al.The AAPS Journal|March 31, 2011
A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate bufferChristina Avanti, Jean-Pierre Amorij, Dewi Setyaningsih, et al.Pageof 4